BARTOLINI, MANUELA
BARTOLINI, MANUELA
DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE
Docenti di ruolo di IIa fascia
'Enzymes' immobilization on monolithic matrices: applications in drug discovery'
2010 Vincenza Andrisano; Manuela Bartolini
(±)- BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease
2021 Ismaili L.; Monnin J.; Etievant A.; Arribas R.L.; Viejo L.; Refouvelet B.; Soukup O.; Janockova J.; Hepnarova V.; Korabecny J.; Kucera T.; Jun D.; Andrys R.; Musilek K.; Baguet A.; Garcia-Frutos E.M.; De Simone A.; Andrisano V.; Bartolini M.; De Los Rios C.; Marco-Contelles J.; Haffen E.
1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies
2014 O Di Pietro; E Viayna; E Vicente-García; M Bartolini; Rosario Ramón; J Juárez-Jiménez; M. V Clos; B Pérez; V Andrisano; F. Javier Luque; R Lavilla; D Muñoz-Torrero
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents
2012 S. Rizzo; A. Tarozzi; M. Bartolini; G. Da Costa; A. Bisi; S. Gobbi; F. Belluti; A. Ligresti; M. Allarà; J-P. Monti; V. Andrisano; V. Di Marzo; P. Hrelia; A. Rampa
3-(4-{[benzyl(methyl)amino]methyl}-phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation: A dual function lead for Alzheimer's disease therapy
2003 Piazzi L.; Rampa A.; Bisi A.; Gobbi S.; Belluti F.; Cavalli A.; Bartolini M.; Andrisano V.; Valenti P.; Recanatini M.
5-Methyl-N-(8-(5,6,7,8-tetrahydroacridin-9-ylamino)octyl)-5 H -indolo[2,3- b] quinolin-11-amine: a highly potent human cholinesterase inhibitor
2017 Wang, Li; Moraleda, Ignacio; Iriepa, Isabel; Romero, Alejandro; López-Muñoz, Francisco; Chioua, Mourad; Inokuchi, Tsutomu; Bartolini, Manuela; Marco-Contelles, José
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion Diseases
2013 Staderini, M; Aulic, S; Bartolini, M; Hoang, NAT; Gonzalez-Ruiz, V; Perez, DI; Cabezas, N; Martinez, A; Martin, MA; Andrisano; Legname, G; Menendez, JC; Bolognesi, ML
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES
2010 Bartolini M.; Naldi M.; Fiori J.; Valle F.; Biscarini F.; Nicolau D.V.; Andrisano V.
A multi-methodological approach for the investigation of β-Amyloid-CORMs interaction: an LC-ESI/MS and Circular Dichroism study.
2018 de simone a, naldi m, tedesco d, bartolini m, andrisano v
A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors
2019 Perez-Areales F.J.; Turcu A.L.; Barniol-Xicota M.; Pont C.; Pivetta D.; Espargaro A.; Bartolini M.; De Simone A.; Andrisano V.; Perez B.; Sabate R.; Sureda F.X.; Vazquez S.; Munoz-Torrero D.
A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017
2018 Andrisano, Vincenza*; Naldi, Marina; De Simone, Angela; Bartolini, Manuela
A small molecule targeting the multifactorial nature of Alzheimer's disease
2007 Cavalli A.; Bolognesi M. L.; Capsoni S.; Andrisano V.; Bartolini M.; Margotti E.; Cattaneo A.; Recanatini M.; Melchiorre C.
Acetylcholinesterase inhibitors: SAR and kinetic studies on ω-[N-methyl-N-(3-alkylcarbamoyloxyphenyl]methyl] aminoalkoxyaryl derivatives
2001 Rampa A.; Piazzi L.; Belluti F.; Gobbi S.; Bisi A.; Bartolini M.; Andrisano V.; Cavrini V.; Cavalli A.; Recanatini M.; Valenti P.
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices
2010 M. Bartolini; M. Naldi; D. V. Nicolau; F.C.M.J.M. van Delft; J. van Zijl; J. Snijder; F.C. van den Heuvel; V. Andrisano
ACETYLCHOLINESTERASE-BASED ANALYTICAL TOOLS FOR DRUG SCREENING
2012 M. Bartolini; M. Naldi; D.V. Nicolau; F.C.M.J.M. van Delft; J. van Zijl; J. Snijder; F.C. van den Heuvel; V. Andrisano
AChE inhibitors: affinity and kinetic studies using SPR technology
2017 Anna Tramarin, Edoardo Fabini, Manuela Bartolini
Advanced analytical methodologies in Alzheimer's disease drug discovery
2020 De Simone A.; Naldi M.; Tedesco D.; Bartolini M.; Davani L.; Andrisano V.
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009
2009 V.Andrisano; M.Bartolini; F.Mancini; M.Naldi
AMYLOID-b-PEPTIDE SELF ASSEMBLY KINETICS BY AFM AND MALDI-TOF MASS SPECTROMETRY
2009 M.Naldi; M. Bartolini; D. Nicolau; V. Andrisano
Analogues of the dual acetylcholinesterase inhibitor AP2238: synthesis and SAR
2004 L. Piazzi; M. Bartolini; F. Belluti; A. Bisi; A. Cavalli; S. Gobbi; A. Rampa; P. Valenti
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
'Enzymes' immobilization on monolithic matrices: applications in drug discovery' | Vincenza Andrisano; Manuela Bartolini | 2010-01-01 | - | ILM Publications | 2.01 Capitolo / saggio in libro | - |
(±)- BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease | Ismaili L.; Monnin J.; Etievant A.; Arribas R.L.; Viejo L.; Refouvelet B.; Soukup O.; Janockova J....; Hepnarova V.; Korabecny J.; Kucera T.; Jun D.; Andrys R.; Musilek K.; Baguet A.; Garcia-Frutos E.M.; De Simone A.; Andrisano V.; Bartolini M.; De Los Rios C.; Marco-Contelles J.; Haffen E. | 2021-01-01 | ACS CHEMICAL NEUROSCIENCE | - | 1.01 Articolo in rivista | - |
1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies | O Di Pietro; E Viayna; E Vicente-García; M Bartolini; Rosario Ramón; J Juárez-Jiménez; M. V Clos;... B Pérez; V Andrisano; F. Javier Luque; R Lavilla; D Muñoz-Torrero | 2014-01-01 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents | S. Rizzo; A. Tarozzi; M. Bartolini; G. Da Costa; A. Bisi; S. Gobbi; F. Belluti; A. Ligresti; M. A...llarà; J-P. Monti; V. Andrisano; V. Di Marzo; P. Hrelia; A. Rampa | 2012-01-01 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
3-(4-{[benzyl(methyl)amino]methyl}-phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation: A dual function lead for Alzheimer's disease therapy | Piazzi L.; Rampa A.; Bisi A.; Gobbi S.; Belluti F.; Cavalli A.; Bartolini M.; Andrisano V.; Valen...ti P.; Recanatini M. | 2003-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
5-Methyl-N-(8-(5,6,7,8-tetrahydroacridin-9-ylamino)octyl)-5 H -indolo[2,3- b] quinolin-11-amine: a highly potent human cholinesterase inhibitor | Wang, Li; Moraleda, Ignacio; Iriepa, Isabel; Romero, Alejandro; López-Muñoz, Francisco; Chioua, M...ourad; Inokuchi, Tsutomu; Bartolini, Manuela; Marco-Contelles, José | 2017-01-01 | MEDCHEMCOMM | - | 1.01 Articolo in rivista | - |
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion Diseases | Staderini, M; Aulic, S; Bartolini, M; Hoang, NAT; Gonzalez-Ruiz, V; Perez, DI; Cabezas, N; Martin...ez, A; Martin, MA; Andrisano; Legname, G; Menendez, JC; Bolognesi, ML | 2013-01-01 | ACS MEDICINAL CHEMISTRY LETTERS | - | 1.01 Articolo in rivista | - |
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES | Bartolini M.; Naldi M.; Fiori J.; Valle F.; Biscarini F.; Nicolau D.V.; Andrisano V. | 2010-01-01 | - | CLEUP sc | 4.02 Riassunto (Abstract) | - |
A multi-methodological approach for the investigation of β-Amyloid-CORMs interaction: an LC-ESI/MS and Circular Dichroism study. | de simone a, naldi m, tedesco d, bartolini m, andrisano v | 2018-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors | Perez-Areales F.J.; Turcu A.L.; Barniol-Xicota M.; Pont C.; Pivetta D.; Espargaro A.; Bartolini M....; De Simone A.; Andrisano V.; Perez B.; Sabate R.; Sureda F.X.; Vazquez S.; Munoz-Torrero D. | 2019-01-01 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017 | Andrisano, Vincenza*; Naldi, Marina; De Simone, Angela; Bartolini, Manuela | 2018-01-01 | EXPERT OPINION ON THERAPEUTIC PATENTS | - | 1.01 Articolo in rivista | - |
A small molecule targeting the multifactorial nature of Alzheimer's disease | Cavalli A.; Bolognesi M. L.; Capsoni S.; Andrisano V.; Bartolini M.; Margotti E.; Cattaneo A.; Re...canatini M.; Melchiorre C. | 2007-01-01 | ANGEWANDTE CHEMIE. INTERNATIONAL EDITION | - | 1.01 Articolo in rivista | - |
Acetylcholinesterase inhibitors: SAR and kinetic studies on ω-[N-methyl-N-(3-alkylcarbamoyloxyphenyl]methyl] aminoalkoxyaryl derivatives | Rampa A.; Piazzi L.; Belluti F.; Gobbi S.; Bisi A.; Bartolini M.; Andrisano V.; Cavrini V.; Caval...li A.; Recanatini M.; Valenti P. | 2001-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices | M. Bartolini; M. Naldi; D. V. Nicolau; F.C.M.J.M. van Delft; J. van Zijl; J. Snijder; F.C. van de...n Heuvel; V. Andrisano | 2010-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
ACETYLCHOLINESTERASE-BASED ANALYTICAL TOOLS FOR DRUG SCREENING | M. Bartolini; M. Naldi; D.V. Nicolau; F.C.M.J.M. van Delft; J. van Zijl; J. Snijder; F.C. van den... Heuvel; V. Andrisano | 2012-01-01 | - | bestprint | 4.02 Riassunto (Abstract) | - |
AChE inhibitors: affinity and kinetic studies using SPR technology | Anna Tramarin, Edoardo Fabini, Manuela Bartolini | 2017-01-01 | - | - | 4.03 Poster | - |
Advanced analytical methodologies in Alzheimer's disease drug discovery | De Simone A.; Naldi M.; Tedesco D.; Bartolini M.; Davani L.; Andrisano V. | 2020-01-01 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | - | 1.01 Articolo in rivista | - |
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009 | V.Andrisano; M.Bartolini; F.Mancini; M.Naldi | 2009-01-01 | - | s.n | 4.01 Contributo in Atti di convegno | - |
AMYLOID-b-PEPTIDE SELF ASSEMBLY KINETICS BY AFM AND MALDI-TOF MASS SPECTROMETRY | M.Naldi; M. Bartolini; D. Nicolau; V. Andrisano | 2009-01-01 | - | s.n | 4.01 Contributo in Atti di convegno | - |
Analogues of the dual acetylcholinesterase inhibitor AP2238: synthesis and SAR | L. Piazzi; M. Bartolini; F. Belluti; A. Bisi; A. Cavalli; S. Gobbi; A. Rampa; P. Valenti | 2004-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |